The Greenwich Biosciences mission is rooted in unlocking the potential of cannabinoid medicines to address serious medical conditions with limited treatment options.

Scroll Arrow Icon

Our vision is to unlock the potential of cannabinoid science to transform the lives of patients and their families

The world has only recently started to recognize the true potential of cannabinoids to help people with challenging conditions. But we have been advancing the science for more than 2 decades. Much of what is known about cannabinoids was discovered by our researchers. And there’s still so much more to learn.

Our mission is to lead the world in developing and commercializing regulatory approved cannabinoid medicines, putting patients first

We created the first-ever controlled clinical trial program evaluating a cannabinoid medicine, for patients with Dravet syndrome, Lennox-Gastaut syndrome (LGS), and Tuberous Sclerosis Complex (TSC). Our products are backed by science, independently vetted, FDA-approved, and consistently manufactured—because we believe no cannabinoid should go to market without the data evaluating its safety profile, efficacy, and its potential to help.

We put patients first

Everyone who works at Greenwich Biosciences is united in one shared belief: that cannabinoids have the incredible potential to transform the lives of patients and families.

Read More


The values we value most

Scroll Arrow Icon

Every day, we strive to be…

Patient Driven

We never forget who we’re striving for


We are here to change lives


We challenge ourselves to find new and better approaches


We accomplish more through working together and valuing one another


We take responsibility and deliver on our commitments

We approach our work with…


We are fair, honest, and ethical


We pursue the highest standards for ourselves and for our industry


View our current openings.

Search Jobs